While KMT2D protein expression and KMT2D mutational status do not seem to have prognostic value in UTUC, they appear to add information to improve clinical decision-making regarding the type of therapy. The gene discussed is KMT2D; the disease is renal pelvis/ureter urothelial carcinoma.